Live Nasdaq Composite: OpenAI IPO Delay Fears Send Markets Out on Sour Note

Investing

Eli Lilly : LLY

All Eli Lilly Articles

652 Articles

Jon C. Ogg | Nov 25, 2014 at 10:34 AM EST

The Best Stocks of 2014 Part 1: Materials, Consumer, Health, Industrials

ThinkstockStocks have enjoyed yet another wonderful year in 2014, and the bull market is now more than five and a…

Lee Jackson | Oct 2, 2014 at 8:55 AM EDT

Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst

The data is grim: cancer is increasing. Sales of these top oncology drugs are likely to increase as well.

Jon C. Ogg | Jul 31, 2014 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: Eli Lilly, Enphase, Lululemon, SodaStream, Yelp and More

These are the top analyst upgrades, downgrades and initiations from Wall Street firms for Thursday, July 31, 2014. They include…

Jon C. Ogg | Jul 2, 2014 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, FireEye, JDSU Uniphase, Solar Stocks and More

These are the top analyst upgrades, downgrades and initiations from Wall Street firms for Tuesday, July 2, 2014. They include…

Jon C. Ogg | May 31, 2014 at 9:06 AM EDT

The Highest-Yielding Dividends That Are Safe to Hold

ThinkstockDividend payments by S&P 500 companies reached an all-time high last year, totaling some $330.8 billion, according to FactSet. As…

cgblaine22 | Apr 26, 2014 at 8:30 AM EDT

Biotech: The Poster Child for Market Volatility in 2014

The NYSE Arca Biotechnology Index fell nearly 9% between a peak on Jan. 22 and a low on Feb. 5.…

Trey Thoelcke | Apr 24, 2014 at 10:55 AM EDT

UPS Joins Others Down in the Dumps

UPS reported first-quarter 2014 results before markets opened Thursday, and no surprise, winter weather was its theme of the day.…

Trey Thoelcke | Apr 24, 2014 at 7:00 AM EDT

Expired Patents Take a Bite out of Eli Lilly Results

Eli Lilly reported disappointing first-quarter 2014 results before markets opened Thursday, due in part to the impact of U.S. patent…

Jon C. Ogg | Apr 3, 2014 at 8:40 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Intel, Chevron, Exxon, Qualcomm, Citigroup and More

These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Thursday, April 3, 2014.…

Trey Thoelcke | Mar 13, 2014 at 8:45 AM EDT

Piper Jaffray Stocks to Buy for S&P 500 Going to 2,100

The chief strategist at Piper Jaffray released his report for March. It details how the second and third quarters typically…

Trey Thoelcke | Mar 10, 2014 at 9:05 AM EDT

Four Upcoming Catalysts That Could Move Pharmaceutical Stocks

In a new research report, Cowen analysts posted a list of some of the top new datapoints cited at the…

Trey Thoelcke | Mar 4, 2014 at 8:50 AM EST

Merrill Lynch’s Top Health Care Stocks to Buy Now

Merrill Lynch likes the health care sector and has made no secret that they think that it can continue to…

Trey Thoelcke | Feb 26, 2014 at 8:25 AM EST

Six New Stocks to Buy in the Piper Jaffray Model Portfolio

Most Wall Street firms run model portfolios for their institutional and retail clients. Here are stocks that recently were added…

Trey Thoelcke | Feb 17, 2014 at 7:05 AM EST

Biotech Buyout Bolsters Novartis Cancer Portfolio

Novartis announced Monday morning that it will acquire privately held startup biotech CoStim Pharmaceuticals. Terms of the deal were not…

Jon C. Ogg | Feb 13, 2014 at 10:40 AM EST

Top Pharma and Biotech Stocks to Buy From Key Investor Conference

With top biotechnology and health care companies from around the world attending the Leerink Global Healthcare, it is a good…

1 … 33 34 35 36 37 … 44

Eli Lilly : LLY

All Eli Lilly Articles

The Best Stocks of 2014 Part 1: Materials, Consumer, Health, Industrials

Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst

Top Analyst Upgrades and Downgrades: Eli Lilly, Enphase, Lululemon, SodaStream, Yelp and More

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, FireEye, JDSU Uniphase, Solar Stocks and More

The Highest-Yielding Dividends That Are Safe to Hold

Biotech: The Poster Child for Market Volatility in 2014

UPS Joins Others Down in the Dumps

Expired Patents Take a Bite out of Eli Lilly Results

Top Analyst Upgrades and Downgrades: Apple, Intel, Chevron, Exxon, Qualcomm, Citigroup and More

Piper Jaffray Stocks to Buy for S&P 500 Going to 2,100

Four Upcoming Catalysts That Could Move Pharmaceutical Stocks

Merrill Lynch’s Top Health Care Stocks to Buy Now

Six New Stocks to Buy in the Piper Jaffray Model Portfolio

Biotech Buyout Bolsters Novartis Cancer Portfolio

Top Pharma and Biotech Stocks to Buy From Key Investor Conference

Live Nasdaq Composite: OpenAI IPO Delay Fears Send Markets Out on Sour Note

Retail REIT CEO Says Consumer Traffic and Demand Have Strengthened Since the Start of 2026

The Quiet Gross Margin Reality Check That Points to a Dangerous Valuation Gap Between Marvell and Broadcom

Apple’s Massive 20% Hardware Price Hikes Just Handed Amazon a Golden AI Ticket

Social Security Pays $1,976 a Month. Here's What a $393,000 Portfolio Generates Instead

The Dividend Strategy That Sends Your Grandkids To College

Micron Just Beat Wall Street and It ‘Reset the Entire Industry’

Retail REIT CEO Says Consumer Traffic and Demand Have Strengthened Since the Start of 2026

Eli Lilly : LLY

All Eli Lilly Articles

The Best Stocks of 2014 Part 1: Materials, Consumer, Health, Industrials

Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst

Top Analyst Upgrades and Downgrades: Eli Lilly, Enphase, Lululemon, SodaStream, Yelp and More

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, FireEye, JDSU Uniphase, Solar Stocks and More

The Highest-Yielding Dividends That Are Safe to Hold

Biotech: The Poster Child for Market Volatility in 2014

UPS Joins Others Down in the Dumps

Expired Patents Take a Bite out of Eli Lilly Results

Top Analyst Upgrades and Downgrades: Apple, Intel, Chevron, Exxon, Qualcomm, Citigroup and More

Piper Jaffray Stocks to Buy for S&P 500 Going to 2,100

Four Upcoming Catalysts That Could Move Pharmaceutical Stocks

Merrill Lynch’s Top Health Care Stocks to Buy Now

Six New Stocks to Buy in the Piper Jaffray Model Portfolio

Biotech Buyout Bolsters Novartis Cancer Portfolio

Top Pharma and Biotech Stocks to Buy From Key Investor Conference

Live Nasdaq Composite: OpenAI IPO Delay Fears Send Markets Out on Sour Note

Retail REIT CEO Says Consumer Traffic and Demand Have Strengthened Since the Start of 2026

The Quiet Gross Margin Reality Check That Points to a Dangerous Valuation Gap Between Marvell and Broadcom

Apple’s Massive 20% Hardware Price Hikes Just Handed Amazon a Golden AI Ticket

Featured Reads

Social Security Pays $1,976 a Month. Here's What a $393,000 Portfolio Generates Instead

The Dividend Strategy That Sends Your Grandkids To College